<DOC>
	<DOCNO>NCT01884012</DOCNO>
	<brief_summary>In randomized-controlled , cross-over trial investigator test effect long-term oxygen therapy ( &gt; 16h/day ) give 5 week wash-out period phase 2 week exercise performance quality life many physiological parameter patient pulmonary arterial chronic thromboembolic pulmonary hypertension .</brief_summary>
	<brief_title>Effect Long-term Oxygen Therapy Exercise Capacity Quality Life Patients With Pulmonary Arterial Chronic Thromboembolic Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Inclusion criterion : Adult patient establish diagnosis pulmonary arterial chronic thromboembolic pulmonary hypertension ( class I IV accord late WHO classification scheme Dana Point 2008 ) optimize medical therapy stable condition least 4 week , desaturate 6 minute walk test =4 % value &lt; 92 % . Exclusion criterion : Patients unstable condition require frequent therapeutic adaption pregnant woman patient pulmonary venous hypertension due leave heart diseases patient relevant concomitant lung disease severe daytime hypoxemia</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>